Skip to main content
Clinical Trials/CTRI/2018/03/012549
CTRI/2018/03/012549
Completed
未知

An evaluation of efficacy of addition of dexmedetomidine/clonidine to fentanyl in Attenuation of Pressor Response of Laryngoscopy and Intubation : A prospective double blind randomized controlled trial

RNT Medical college0 sites96 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
RNT Medical college
Enrollment
96
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
September 29, 2017
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\)Scheduled for elective surgeries under general anaesthesia 2\)ASA grade I and II

Exclusion Criteria

  • 1\)Baseline heart rate less than 60 per minute
  • 2\)Baseline blood pressure less than 100/50 mm of hg 3\)Reactive airway disease
  • 4\)History of cardiac disease and hypertensive patient
  • 5\)Requiring 2 or more attempts for laryngoscopy and intubation will be excluded from the study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A clinical trial on effects of the drug dexmedetomidine over pain after surgery in patients undergoing groin hernia surgeries when it is added to local anaesthetic solution used to block the conduction of pain perception through the nerves
CTRI/2018/12/016815Gopalakrishnan K50
Active, not recruiting
Not Applicable
Confronto degli effetti di due sedativi, la dexmedetomidina e il propofol, in pazienti che hanno bisogno di ricominciare a respirare senza un macchinario e che hanno difficolta' a farlo.Patients requiring mechanical ventilation and sedation in the ICUMedDRA version: 14.1Level: PTClassification code 10039897Term: SedationSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 14.1Level: SOCClassification code 10029205Term: Nervous system disordersSystem Organ Class: 10029205 - Nervous system disordersTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
EUCTR2011-001490-40-ITORION CORPORATION ORION PHARMA
Recruiting
Phase 3
The effect of Dexmedetomidine in pediatric Electroconvulsive therapyCondition 1: Blood Pressure. Condition 2: Heart Rate.Elevated blood-pressure reading, without diagnosis of hypertensionTachycardia, unspecifiedR03.0R00.0
IRCT20160307026950N29Esfahan University of Medical Sciences70
Completed
Phase 3
Dexmedetomidine in rhinoplasty
IRCT20211225053519N3Tehran University of Medical Sciences42
Recruiting
Phase 3
Comparision of Dexmedetomidine and Fentanyl in pain control.
IRCT20200613047760N1Ahvaz University of Medical Sciences56